Related Experiment Video
Updated: Nov 23, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype
Janelle Cheung1, Noor A Lokman1, Riya D Abraham1
1Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Abstract:
Follicle-stimulating hormone (FSH) and luteinising hormone (LH) play important roles in regulating cell growth and proliferation in the ovary. However, few studies have explored the expression of FSH and LH receptors (FSHR and LHCGR) in ovarian cancer, and their functional roles in cancer progression remain inconclusive. This study investigated the potential impact of both mRNA (FSHR, LHCGR) and protein (FSHR, LHCGR) expression on ovarian cancer progression using publicly available online databases, qRT-PCR (high grade serous ovarian cancers, HGSOC, n = 29 and benign ovarian tumors, n = 17) and immunohistochemistry (HGSOC, n = 144). In addition, we investigated the effect of FSHR and LHCGR siRNA knockdown on the pro-metastatic behavior of serous ovarian cancer cells in vitro. High FSHR or high LHCGR expression in patients with all subtypes of high-grade ovarian cancer was significantly associated with longer progression-free survival (PFS) and overall survival (OS). High FSHR protein expression was associated with increased PFS (p = 0.050) and OS (p = 0.025). HGSOC patients with both high FSHR and high LHCGR protein levels had the best survival outcome, whilst both low FSHR and low LHCGR expression was associated with poorest survival (p = 0.019). Knockdown of FSHR significantly increased the invasion of serous ovarian cancer cells (OVCAR3 and COV362) in vitro. LHCGR knockdown also promoted invasion of COV362 cells. This study highlights that lower FSHR and LHCGR expression is associated with a more aggressive epithelial ovarian cancer phenotype and promotes pro-metastatic behaviour.
Insights
Lower expression of follicle-stimulating hormone receptor (FSHR) and luteinising hormone receptor (LHCGR) is linked to aggressive ovarian cancer and increased metastasis. Higher expression of these receptors correlates with better patient survival outcomes.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Follicle-stimulating hormone (FSH) and luteinising hormone (LH) are crucial for ovarian function.
- The roles of FSH and LH receptors (FSHR, LHCGR) in ovarian cancer progression are not well understood.
- Previous research has limited data on FSHR and LHCGR expression in ovarian cancer.
Purpose of the Study:
- To investigate the impact of FSHR and LHCGR mRNA and protein expression on ovarian cancer progression.
- To determine the functional role of FSHR and LHCGR in the pro-metastatic behavior of ovarian cancer cells.
- To correlate receptor expression levels with patient survival outcomes.
Main Methods:
- Analysis of publicly available databases for mRNA and protein expression.
- Quantitative reverse transcription PCR (qRT-PCR) on ovarian cancer and benign tumor samples.
- Immunohistochemistry on high-grade serous ovarian cancer (HGSOC) patient samples.
- In vitro siRNA knockdown of FSHR and LHCGR in ovarian cancer cell lines.
Main Results:
- High FSHR or LHCGR expression in ovarian cancer patients was associated with significantly longer progression-free survival (PFS) and overall survival (OS).
- High FSHR protein expression correlated with improved PFS and OS.
- Combined high expression of both FSHR and LHCGR indicated the best survival outcomes, while low expression of both predicted the poorest survival.
- FSHR knockdown increased invasion in OVCAR3 and COV362 cells; LHCGR knockdown promoted invasion in COV362 cells.
Conclusions:
- Lower expression of FSHR and LHCGR is linked to a more aggressive ovarian cancer phenotype.
- Reduced FSHR and LHCGR expression promotes pro-metastatic behavior in ovarian cancer cells.
- FSHR and LHCGR expression levels may serve as prognostic biomarkers for ovarian cancer.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Oogenesis
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

